Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer. - Wikidata - awgldk - TriplyDB

Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer.

Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer.

http://www.wikidata.org/entity/Q34366342

about

Critical appraisal of trastuzumab in treatment of advanced stomach cancer Phase I study of epirubicin, cisplatin and capecitabine plus matuzumab in previously untreated patients with advanced oesophagogastric cancer Taxanes in the Treatment of Advanced Gastric Cancer Chemotherapy in Elderly Patients with Gastric Cancer Second-line treatment of metastatic gastric cancer: Current options and future directions Optimal first-line chemotherapeutic treatment in patients with locally advanced or metastatic esophagogastric carcinoma: triplet versus doublet chemotherapy: a systematic literature review and meta-analysis Clinical practice guidelines for gastric cancer in Korea: an evidence-based approach Is conversion therapy possible in stage IV gastric cancer: the proposal of new biological categories of classification Determination of prognostic factors in Japanese patients with advanced gastric cancer using the data from a randomized controlled trial, Japan clinical oncology group 9912.Infusional 5-fluorouracil, cisplatin and mitomycin C in advanced gastric cancer: a low cost effective regimen Irinotecan is active in chemonaive patients with metastatic gastric cancer: a phase II multicentric trial.Phase II study of capecitabine and cisplatin as first-line combination therapy in patients with gastric cancer recurrent after fluoropyrimidine-based adjuvant chemotherapy A phase II study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid (FOLFOX-4) as first-line treatment of advanced gastric cancer patients.Salvage chemotherapy with irinotecan, 5-fluorouracil and leucovorin for taxane- and cisplatin-refractory, metastatic gastric cancer Docetaxel combined with oral etoposide as second-line treatment for advanced gastric carcinoma after failure of platinum- and fluoropyrimidine-based regimens.Phase II study of oxaliplatin plus S-1 as first-line treatment for advanced gastric cancer (G-SOX study).A prospective phase II study of cetuximab in combination with XELOX (capecitabine and oxaliplatin) in patients with metastatic and/or recurrent advanced gastric cancer.Combination chemotherapy of heptaplatin, paclitaxel and 5-fluorouracil in patients with advanced gastric cancer: a pilot study.A phase II study of S-1 and oxaliplatin (SOx) combination chemotherapy as a first-line therapy for patients with advanced gastric cancer.Irinotecan-involved regimens for advanced gastric cancer: a pooled-analysis of clinical trials Docetaxel plus oxaliplatin in combination with capecitabine as first-line treatment for advanced gastric cancer.Irinotecan plus mitomycin C as second-line chemotherapy for advanced gastric cancer resistant to fluoropyrimidine and Cisplatin: a retrospective study.A phase I trial of bortezomib in combination with epirubicin, carboplatin and capecitabine (ECarboX) in advanced oesophagogastric adenocarcinoma.Third-line docetaxel chemotherapy for recurrent and metastatic gastric cancer.Efficacy and tolerability of chemotherapy with modified dose-dense TCF regimen (TCF-dd) in locally advanced or metastatic gastric cancer: final results of a phase II trial.Mitomycin C and capecitabine in pretreated patients with metastatic gastric cancer: a multicenter phase II study.Prospective phase II trial of pazopanib plus CapeOX (capecitabine and oxaliplatin) in previously untreated patients with advanced gastric cancer Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer.A phase II trial of etoposide, leucovorin and 5-fluorouracil (ELF) in patients with advanced gastric cancer.The GYMSSA trial: a prospective randomized trial comparing gastrectomy, metastasectomy plus systemic therapy versus systemic therapy alone Combination chemotherapy with 5-fluorouracil and heptaplatin as first-line treatment in patients with advanced gastric cancer.Paclitaxel/oxaliplatin/fluorouracil (TOF) regimen versus S-1/oxaliplatin (SOX) regimen for metastatic gastric cancer patients.Oxaliplatin, 5-fluorouracil and leucovorin (FOLFOX-4) combination chemotherapy as a salvage treatment in advanced gastric cancer Paclitaxel combined with capecitabine as first-line chemotherapy for advanced or recurrent gastric cancer.Thymidine Phosphorylase/β-tubulin III expressions predict the response in Chinese advanced gastric cancer patients receiving first-line capecitabine plus paclitaxel.Combination therapy with docetaxel and S-1 as a first-line treatment in patients with advanced or recurrent gastric cancer: a retrospective analysis Management of upper gastrointestinal cancers.S9511: a Southwest Oncology Group phase II study of trimetrexate, 5-fluorouracil, and leucovorin in unresectable or metastatic adenocarcinoma of the stomach.Recent advances in chemotherapy for advanced gastric cancer Liver resections in metastatic gastric cancer

P2860

Q24604411-23C7600E-DBC1-4117-8B40-8B0722E69E7F Q24649684-9A446C3F-7658-489B-8002-6E23E34E0559 Q26747708-690C6770-9F54-4B00-BF3A-07F16CF83186 Q26771424-F0084BC7-9575-42B5-BAA9-884B059FDFB6 Q26778027-086244B8-5223-4B5F-BB9A-93C31BE207AA Q26798400-CA09B82D-2E66-49E0-B274-36C0706C269E Q26828506-28412977-E6E4-4292-ADA3-AB31F3F340A8 Q28084888-C2FE4ED9-34DF-42A1-AB48-F9929421E2BD Q30785622-238D9037-5AAA-4D02-9407-546B5BB36B9A Q33341264-241458DE-FD54-488E-AA28-C941F532F45F Q33349888-6C588230-A7A1-4889-B48C-1BAE8D6CBEE2 Q33364558-DD42DF6A-8BD3-4E00-88BB-7ED943BFFDDD Q33366008-1C686237-E080-449E-9780-FDDA837B07BC Q33366124-E8D79927-9CBC-4CE7-B4E5-E0C5FAC3E0E4 Q33386661-F270A389-B601-4AE3-981A-868F8F7C9508 Q33386875-F616AE9A-C6E6-40C9-9011-72496E721E7A Q33387432-D6748ADF-E352-46C7-9779-730CABAE8D06 Q33389160-F9BEBB2D-8786-4C0C-8929-D4580C10E951 Q33391384-23A418F6-C3E8-4891-AB05-89A756A3AAF4 Q33393276-73228DD2-2FD8-412A-89CB-3D9A7CA754E6 Q33396506-69601205-E768-46EE-BE0A-1D320C51AB56 Q33400558-36A8E461-7A02-4FF6-A740-437D0F078C4D Q33407672-468DFD05-7BA8-4815-B98A-758283B28EA4 Q33407797-EAD826BA-7F2C-4C16-AF8A-5B3E457D5321 Q33411751-3ED83244-BC4D-4508-91A4-49E4898C3FD1 Q33413448-0338AFB7-16AD-4C43-856A-89D066CF4331 Q33430940-0BD90F0E-2CB3-47DD-AAE2-7BA26E49716E Q33488159-B655F70A-EA46-463E-8C0B-380872EEE378 Q33497325-6E26FBEA-8E1E-4770-B12F-07A3772BD248 Q33577629-87EE3C44-D596-46E3-9AC0-6BFAE8587FFA Q33631546-8316A441-E868-445E-A780-E3C490CD6BC8 Q33728364-892BBDDB-4ACA-4726-80B9-23739B5D9502 Q33766456-9C2CA1CA-2F09-4D37-BE47-F7AF7D52078B Q33778285-48439702-2D10-4541-AD9A-F8F7838CD9BA Q33903541-F830CFC8-96B0-43D1-B479-D8798CF1B538 Q33912151-D57FFAA4-9070-40D3-961D-81A91677D457 Q34175118-6A9A8D8B-C1DE-42B2-AB31-2B10C98C277E Q34257451-E56AE764-B2A5-4D4E-A37C-4FBA463D2155 Q34389753-BCB90661-40E9-478C-A9A5-25AF327A250D Q34394426-9B6A2D46-D5D0-4F39-A847-485F42C82CF7

P2860

Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer.

http://www.wikidata.org/entity/Q34366342

description

1993 nî lūn-bûn

@nan

1993 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

1993 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

1993年の論文

@ja

1993年論文

@yue

1993年論文

@zh-hant

1993年論文

@zh-hk

1993年論文

@zh-mo

1993年論文

@zh-tw

1993年论文

@wuu

name

Modified therapy with 5-fluoro ...... te in advanced gastric cancer.

@ast

Modified therapy with 5-fluoro ...... te in advanced gastric cancer.

@en

Modified therapy with 5-fluoro ...... te in advanced gastric cancer.

@nl

type

label

Modified therapy with 5-fluoro ...... te in advanced gastric cancer.

@ast

Modified therapy with 5-fluoro ...... te in advanced gastric cancer.

@en

Modified therapy with 5-fluoro ...... te in advanced gastric cancer.

@nl

prefLabel

Modified therapy with 5-fluoro ...... te in advanced gastric cancer.

@ast

Modified therapy with 5-fluoro ...... te in advanced gastric cancer.

@en

Modified therapy with 5-fluoro ...... te in advanced gastric cancer.

@nl

P1433

Q34366342-97A15813-C50B-4173-95BB-4F2BD7CC69FF

P1476

Q34366342-D08ED306-2531-4134-94A3-39D7A512FF37

P2093

Q34366342-2ECCF941-4457-4738-BEB1-B46D6463741D

Q34366342-63FB103F-F107-41D2-8C83-935AD3D844A2

Q34366342-77A3F086-BE01-4498-B8BB-0D5E75C722DE

Q34366342-98D65F35-FE92-43C6-957E-9C2EB746BAA2

Q34366342-B3F97A74-A994-4AD6-BCF0-05DA505C2C3F

Q34366342-CC0EAB2B-E8D6-4D09-B6DC-76DDBA2F08CC

P2860

Q34366342-6AEA0169-7920-45A4-BA1F-1984241F9B43

P304

Q34366342-E637E2CF-A5D7-4344-B776-4358CAB2C527

P31

Q34366342-0AC75483-4A0B-4485-BC4F-AB0E798A5706

P356

Q34366342-AD9349F5-B737-443A-A482-33CD0117F125

P407

Q34366342-2EF6B412-B787-4632-AE65-28A4D90C8F67

P433

Q34366342-F85246E1-FD1F-4F24-8D92-5EA3771D56AB

P478

Q34366342-187AE3C4-1BB0-453C-B121-1CCDD32C71C2

P577

Q34366342-91E59448-3BBB-4E38-9C55-1C0351350808

P698

Q34366342-2011BDFE-DBE9-4899-8E58-A6A79ECAE286

P356

1097-0142(19930701)72:1%3C37::AID-CNCR2820720109%3E3.0.CO;2-P

P1433

P1476

Modified therapy with 5-fluoro ...... te in advanced gastric cancer.

@en

P2093

Murad AM

http://www.w3.org/2001/XMLSchema#string

Petroianu A

http://www.w3.org/2001/XMLSchema#string

Rausch M

http://www.w3.org/2001/XMLSchema#string

Rocha PR

http://www.w3.org/2001/XMLSchema#string

Rodrigues MA

http://www.w3.org/2001/XMLSchema#string

Santiago FF

http://www.w3.org/2001/XMLSchema#string

P2860

5-Fluorouracil, doxorubicin, and mitomycin (FAM) combination chemotherapy for advanced gastric cancer.

P304

37-41

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/1097-0142(19930701)72:1<37::AID-CNCR2820720109>3.0.CO;2-P

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

72

http://www.w3.org/2001/XMLSchema#string

P577

1993-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

8508427

http://www.w3.org/2001/XMLSchema#string